Table of Contents
1 INDUSTRY OUTLOOK 9
1.1 Industry overview 9
1.2 Industry Trends 9
1.3 Total addressable market 10
1.4 Trends of cancer therapy market 11
2 Report Outline 11
2.1 Report Scope 11
2.2 Report Summary 12
2.3 Research Methodology 12
2.4 Report Assumptions 13
3 Market Snapshot 14
3.1 Market Definition - Infoholic Research 14
3.2 Segmented Addressable Market (SAM) 14
3.3 Trends of the oncology drugs market 15
3.4 Related Markets 16
3.4.1 Over the counter drugs (OTC) 16
3.4.2 Active pharmaceutical ingredients (APIs) 17
3.4.3 Diabetes Drugs 17
4 Market Outlook 18
4.1 Oncology Drugs Approved by FDA (2014 - 2018) 18
4.2 Market segmentation 22
4.3 PEST Analysis 23
4.4 Porter 5(Five) Forces 24
5 Market Characteristics 25
5.1 DRO - Global Oncology Drugs Market Dynamics 25
5.1.1 Drivers 25
5.1.1.1 Increasing incidence of cancer across the globe 25
5.1.1.2 Growing geriatric population 26
5.1.1.3 Expiration of patents 26
5.1.2 Opportunities 27
5.1.2.1 Growing focus on personalized medicine 27
5.1.2.2 Increasing healthcare spending 27
5.1.3 Restraints 28
5.1.3.1 High cost of the drug 28
5.1.3.2 Side effects of oncology drugs 28
6 Therapeutic modality: Market Size and Analysis 31
6.1 Overview 31
6.2 Chemotherapy 32
6.3 Targeted therapy 33
6.4 Immunotherapy 34
6.5 Others 35
7 Application: Market Size and Analysis 37
7.1 Overview 37
7.2 Blood cancer 37
7.3 Breast cancer 38
7.4 Gastro intestinal cancer 39
7.5 Lung cancer 39
7.6 Prostate cancer 40
7.7 Others 40
8 Regions: Market Size and Analysis 41
8.1 Overview 41
8.2 North America 42
8.2.1 Overview 42
8.2.2 US 43
8.2.3 Canada 44
8.3 Europe 44
8.3.1 Overview 44
8.3.2 UK 45
8.3.3 Germany 46
8.3.4 France 46
8.3.5 Italy 46
8.4 APAC 47
8.4.1 Overview 47
8.4.2 India 48
8.4.3 China 48
8.5 Rest of the World 49
9 Competitive Landscape 50
9.1 Overview 50
10 Vendor Profiles 53
10.1 F.Hoffmann-La Roche Ltd 53
10.1.1 Overview 53
10.1.2 Business Unit 56
10.1.3 Geographic Presence 57
10.1.4 58
10.1.5 Business Focus 58
10.1.6 SWOT Analysis 58
10.1.7 Business Strategy 59
10.2 Novartis AG 60
10.2.1 Overview 60
10.2.2 Business Unit 63
10.2.3 Geographic Presence 63
10.2.4 Business Focus 64
10.2.5 SWOT Analysis 64
10.2.6 Business Strategy 65
10.3 Bristol-Myers Squibb 66
10.3.1 Overview 66
10.3.2 Geographic Presence 70
10.3.3 Business Focus 71
10.3.4 SWOT Analysis 71
10.3.5 Business Strategy 72
10.4 Celgene Corporation 73
10.4.1 Overview 73
10.4.2 Geographic Presence 75
10.4.3 Business Focus 75
10.4.4 SWOT Analysis 75
10.4.5 Business Strategy 76
10.5 Johnson & Johnson 77
10.5.1 Overview 77
10.5.2 Business Units 80
10.5.3 Geographic Revenue 81
10.5.4 Business Focus 82
10.5.5 SWOT Analysis 83
10.5.6 Business Strategies 83
10.6 Pfizer Inc.' 84
10.6.1 Overview 84
10.6.2 Geographic Presence 87
10.6.3 Business Focus 88
10.6.4 SWOT Analysis 89
10.6.5 Business Strategies 89
11 Companies to Watch For 90
11.1 Astra Zenca PLC 90
11.1.1 Overview 90
11.2 Eli Lilly and Company. 91
11.2.1 Overview 91
11.3 GlaxoSmithKline plc 92
11.3.1 Overview 92
11.4 Merck & Co. 94
11.4.1 Overview 94
11.5 Sanofi 95
11.5.1 Overview 95
11.6 Amgen Inc. 96
11.6.1 Overview 96
11.7 AbbVie' Inc. 98
11.7.1 Overview 98
12 Annexure 100
12.1 Abbreviations 100